SARS-CoV-2 Spike RBD Nanobody, HRP conjugated
CSB-RA33245B2GMY
ApplicationsELISA
Product group Antibodies
ReactivityVirus
TargetS
Overview
- SupplierCusabio
- Product NameSARS-CoV-2 Spike RBD Nanobody, HRP conjugated
- Delivery Days Customer20
- ApplicationsELISA
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDA1
- ConjugateHRP
- Gene ID43740568
- Target nameS
- Target descriptionsurface glycoprotein
- Target synonymsGU280_gp02, spike glycoprotein, surface glycoprotein
- IsotypeIgG1
- Protein IDP0DTC2
- Protein NameSpike glycoprotein
- ReactivityVirus
- Storage Instruction-20°C or -80°C
- UNSPSC41116161


![Inhibition analysis of immobilized recombinant SARS-CoV-2 (COVID-19) Spike RBD protein, His tag (active) (GTX136090-pro) (coated at 2 μg/mL) binding to soluble recombinant Human ACE2 (ECD) protein, mouse IgG Fc tag (active) (GTX135683-pro) (1000 ng/mL). ACE2 binding was inhibited by increasing concentrations of SARS-CoV-2 (COVID-19) Spike RBD antibody [HL1003-HU] (GTX635866) (0.09-66.67 nM). Bound ACE2 was detected by Goat Anti-Mouse IgG antibody (HRP) (GTX213111-01) (1:10000).](https://www.genetex.com/upload/website/prouct_img/normal/GTX635866/GTX635866_44179_20210712_Neutralizing_Inhibition_w_23061202_325.webp)



